Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The anemia of chronic disease (also called anemia of inflammation) is an acquired disorder of iron homeostasis associated with infection, malignancy, organ failure, trauma, or other causes of inflammation. It is now widely accepted that induction of hepcidin expression in response to inflammation might explain the characteristic hypoferremia associated with this condition. To determine the role of hepcidin in acute inflammation and the regulation of its receptor, the iron exporter, ferroportin, wild-type, heterozygote and hepcidin knockout mice (Hepc-/-) were challenged with sublethal doses of lipopolysaccharide (LPS). Six hours after injection, ferroportin mRNA and protein levels were assessed in the duodenum and the spleen and plasma iron was determined. Our results demonstrate that hepcidin is crucial, though not the sole mediator of LPS-mediated acute hypoferremia, and also that hepcidin major contribution relies on decreased ferroportin protein levels found in the spleen. Furthermore, we establish that LPS-mediated repression of the membrane iron transporter DMT1 and oxidoreductase Dcytb in the duodenum is independent of hepcidin. Finally, our results in the hepc+/- mice indicate that elevated hepcidin gene expression is not a prerequisite for the setting of hypoferremia during early inflammatory response, and they highlight the intimate crosstalk between inflammatory and iron-responsive pathways for the control of hepcidin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The hypoferremia of inflammation is absent [16,17] or greatly attenuated [18] in hepcidin knockout (KO) mice.”
From Iron and infection (2018) · cites this paper as [18]
In the citing paper
“Similarly, reduction of spleen Fpn mRNA level by TLR4 agonist was shown to be HAMP independent (38).”
From Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection (2017) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LPS/TLR4 signal transduction pathway
Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301 · cited 1×
“It is now well established that LPS mediates its effects through a member of the highly conserved Toll-like receptor (TLR) family, TLR4, for the induction of proinflammatory genes [1].”
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282 · cited 1×
“Hepcidin binding to ferroportin induces its internalization and degradation, resulting in cellular iron retention, decreased iron export and hypoferremia (for review, [3]).”
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587 · cited 1×
“Indeed, in the BMP6 KO mice presenting, similarly to the iron deficient mice [25], a reduced activation of the pathway, the hepcidin response to LPS is greatly enhanced despite the important iron load [26].”
Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498
Canonne-Hergaux, F., Gruenheid, S., Ponka, P., & Gros, P. (1999) · Blood · doi:10.1182/blood.v93.12.4406 · Cited by 451 · cited 2×
“The authors acknowledge François Canonne-Hergaux for the generous gift of DMT1 antibody.”
Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R.-H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143354 · Cited by 437 · cited 1×
“Indeed, in the BMP6 KO mice presenting, similarly to the iron deficient mice [25], a reduced activation of the pathway, the hepcidin response to LPS is greatly enhanced despite the important iron load [26].”
Self-citationHemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload
Niederkofler, V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25683 · Cited by 372 · cited 1×
“in 2005 who showed, as reported [27], a rapid and selective extinction of hemojuvelin expression in the liver during acute inflammation [28].”
Iron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322 · cited 1×
“Endotoxic shock is not only associated with an extreme proinflammatory response but is also accompanied by hypoferremia, a primitive defensive mechanism which contributes to allowing reducing circulating iron, while minimising its availability to pathogens (for review, [2]).”
Zhang, D.-L., Hughes, R. M., Ollivierre-Wilson, H., Ghosh, M. C., & Rouault, T. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.006 · Cited by 281 · cited 1×
“Noteworthy, the same inhibitory effect of LPS was obtained for the two recently reported isoforms of ferroportin 1A and 1B in the duodenum and in the spleen [15] (Figure S3).”
Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis
Lesbordes-Brion, J.-C., Viatte, L., Bennoun, M., Lou, D.-Q., Ramey, G., Houbron, C., Hamard, G., Kahn, A., & Vaulont, S. (2006) · Blood · doi:10.1182/blood-2006-02-003376 · Cited by 257 · cited 2×
“Plasma iron was determined as previously described [7].”
Self-citation
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Drakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.006 · Cited by 638
“Suppression of Fpn1 mRNA by the bacteria Pseudomonas aeruginosa requires intact TLR4 (Huang et al., 2012; Peyssonnaux et al., 2006), whereas the Mycoplasma -derived molecule FSL1 decreases Fpn1 in a TLR2-dependent fashion (Guida et al., 2015); however the decrease of Fpn1 mRNA by LPS and the TLR3 ligand poly(I:C) do n…”
BackgroundInfluentialLipocalin 2: an emerging player in iron homeostasis and inflammation
Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426
Ganz, T. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2366-2 · Cited by 270
“Hepcidin-independent effects of inflammation on ferroportin have also been reported in mice treated with lipopolysaccharide [18, 25] but it is not clear what role they play during microbial infections (Fig.”
BackgroundHepcidin regulation in the anemia of inflammation
Wang, C.-Y., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 250
Metadata
- Authors
- Deschemin, J.-C., & Vaulont, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Vaulont, Sophie
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-23
- Volume
- 8
- Issue
- 4
- Pages
- e61050
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3634066
- OpenAlex
- W2009876352
- Cited by
- 89
- References
- 31
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 12 · 2016: 6 · 2015: 12 · 2014: 5 · 2013: 5
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Johns Hopkins University
- Agence Nationale de la Recherche
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hepcidin, hypoferremia, acute inflammation, anemia of chronic disease, iron homeostasis, ferroportin, lipopolysaccharide, DMT1, Dcytb, duodenum, spleen, iron export
- MeSH terms
- Iron Deficiencies, Ferroportin, Acute Disease, Animals, Duodenum, Gene Expression Regulation, Inflammation, Iron, Lipopolysaccharides, Liver, Male, Mice, Inbred C57BL, Organ Specificity, Cation Transport Proteins, Mice, Gene Knockout Techniques, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation. https://app.cochat.ai/papers/10.1371/journal.pone.0061050
- The paper
- Deschemin, J.-C., & Vaulont, S. (2013). Role of Hepcidin in the Setting of Hypoferremia during Acute Inflammation. PLoS ONE. https://doi.org/10.1371/journal.pone.0061050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.